Immune checkpoint inhibition for the treatment of mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibition for the treatment of mesothelioma

Published:2019-05-02 Issue:7 Volume:19 Page:697-706
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Nowak Anna K¹²³^ORCID,McDonnell Alison¹²³,Cook Alistair¹²³^ORCID

Affiliation:

1. National Centre for Asbestos Related Diseases, University of Western Australia, Crawley, Australia

2. Institute for Respiratory Health, University of Western Australia, Nedlands, Australia

3. Medical School, University of Western Australia, Crawley, Australia

Funder

the National Health and Medical Research Council

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2019.1606209

Reference89 articles.

1. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data

2. Impact of an asbestos cement factory on mesothelioma incidence: Global assessment of effects of occupational, familial, and environmental exposure

3. Where Occupation and Environment Overlap: US Forest Service Worker Exposure to Libby Amphibole Fibers

4. Asbestos use and asbestos-related diseases in Asia: Past, present and future

5. Malignant pleural mesothelioma: an update on diagnosis and treatment options

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma;Pathology - Research and Practice;2023-12

2. Repurposing therapeutics for malignant pleural mesothelioma (MPM) – Updates on clinical translations and future outlook;Life Sciences;2022-09

3. A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma;Cancers;2022-05-20

4. Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases;Cancers;2022-02-15

5. “PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”;Seminars in Nuclear Medicine;2021-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3